A food company spends $25 Million in the research stage and $15 Million in the development stage on the development of plant-based meat substitutes. Which of the following represents the appropriate treatment under IFRS? All $40 Million is expensed Only $25 Million is expensed and $15 Million is capitalized, if the $15 Million was incurred after the IFRS criteria for capitalization of development was met. Only $15 Million is expensed and $25 Million is capitalized, if the $25 million was incurred after the IFRS criteria for capitalization of development was met. Nothing is expensed and $40 Million is capitalized Fact Set. Possible outcomes from a class-action lawsuit are 20% chance of paying $10M,20% chance of paying $20M, 20% chance of paying $30M,20% chance of paying $40M and 20% chance of paying nothing. What is the amount of the loss or expense related to this lawsuit under GAAP? No loss is recorded $10M $20M $25M $30M